Our 2023 Sponsors & Partners Included...

Our speakers over all four meetings

27-28 April 2023 | Stockholm

The programme for the Nordic Precision Medicine Forum 2024 is currently in production and more speakers will be added in the coming months of 2023.

If you are interested in presenting, please contact Joel Hornby


Keynote and Plenary Speakers from Nordic Precision Medicine Forum and Nordic Oncology Forum earlier in 2023.

All Speakers from Nordic Precision Medicine Forum and Nordic Oncology Forum in 2023.

Abhishek Niroula, Assistant Professor of Data-Driven Precision Medicine and Diagnostics, University of Gothenburg, Sweden

Alexander Eggermont, Professor of Oncological Surgery, General Director of Gustave Roussy, Gustave Roussy Cancer Campus, France

Anders Edsjö, Vice-Chair of GMS management team, Section Head and Senior Molecular Pathologist, Genomic Medicine Sweden (GMS), Sweden

Anders Ekholm, Senior Adviser, Institute for Futures studies, Norway

Anders Stahlberg, Associate Professor, Sahlgrenska Cancer Center, University of Gothenberg, Sweden

Angus Dalgleish, Professor, Oncology & Infection & Immunity, St Georges Hospital, UK

Anikó Kovács, Associate Professor, Chief Doctor Pathologist, Sahlgrenska University Hospital, Sweden

Anna Bodén, MD Consultant Pathologist, Region Östergötland, Sweden

Anna Pasetto, Associate Professor, University of Oslo and Director of the Center for Advanced Cell Therapy (ACT), Cancer Clinic, Oslo University Hospital, Norway

Anne-Marie Vangsted, Executive Vice President, Statens Serum Institut (SSI), Denmark, Denmark

Antonella Cardone, Secretariat, Cancer Patients Europe, Italy

Åslaug Helland, Oncologist, Oslo University Hospital, Norway

Balazs Acs, Senior Postdoctoral Fellow, Karolinska Institutet, Sweden

Begonya Nafria Escalera, Patient Engagement in Research Coordinator, Sant Joan de Déu Research Foundation, Spain

Bettina Lundgren, CEO and Managing Director, Danish National Genome Centre, Denmark

Bettina Ryll, Founder Melanoma Patient Network Europe and Strategist Nollvision cancer, Sweden

Carl Savage, Senior Researcher, Halmstad University, Sweden

Clare Balendran, VP and Head of Translational Development, Novo Nordisk, Denmark

Claudia Pagliari, Director, Global eHealth Group, Centre for Population Health Sciences, The University of Edinburgh, UK

Corrado D’Arrigo, Consultant Histopathologist, Dorset County Hospital Foundation Trust, UK

Daniel Lasserson, Professor of Acute Ambulatory Care, Warwick University and Clinical Lead, Acute Hospital at Home, John Radcliffe Hospital, UK

Daniel Lundqvist, Director of CIR, Centre for Imaging Research, Sweden

Darren Treanor, Director, NPIC and Consultant pathologist, Leeds Teaching Hospitals NHS Trust, UK

Ditte Demontis, Professor, Biomedicine, Aarhus University, Denmark

Ebba Hallersjo Hult, Co-founder and Head of Vision Zero Cancer, Sweden

Ed Schuuring, Professor & Head, Molecular Pathology, University Medical Center Groningen, Netherlands

Elena Netsi, Senior Research Manager, Wellcome’s Mental Health Translation team, UK

Elina Drakvik, Specialist, The Finnish Innovation Fund Sitra, Finland

Emiel Janssen, Professor, Pathology Unit, Stavanger University Hospital, Sweden

Emilia Andersson, Pathologist, oncology lead, Medical & Government Affairs, Roche, Sweden

Eugenia Colón, Head of Breast Pathology Unit, Unilabs-Sweden, Sweden

Frida Lundmark, Policy expert, Lif – the Research Pharmaceutical Companies Association, Sweden

Gal Cafri, Immunotherapy and Genetic Engineering Group leader, Sheba Medical Center, Israel

Georgi Natchev, CEO, Digiburn, Bulgaria

Graham Belfield, Director NGS & Transcriptomics, AstraZeneca, Sweden

Hans Gelderblom, Medical Oncologist, Leiden University Medical Center, Netherlands

Hans van der Vliet, CSO, LAVA therapeutics, Netherlands

Harry Hallock, Senior Researcher, DNV, Norway

Helga Brøgger, Principal researcher, DNV, Norway

Ivan Diaz Padilla, Vice-President, Global Clinical Head, Immuno-Oncology, GSK, Switzerland

Iwona Lugowska, Professor, Head of Precision Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Poland

Janne Lehtiö, Professor, Group Leader, Cancer Proteogenomics, Karolinska Institutet, Sweden

Joakim Börjesson, Director of Digital Health, RISE (Research Institutes of Sweden), Sweden

Joel Hedlund, Data Director CMIV/AIDA, Linköping University, Sweden

Johan Kolmert, Senior Research Scientist, Karolinska Institute, Sweden

Johan Lindberg, Professor of oncology and chief physician, Department of Oncology-Pathology, Karolinska University Hospital, Sweden

Johan Lundin, Research Director, Institute for Molecular Medicine Finland, Professor, Karolinska Institutet, University of Helsinki, Finland

Johanna Bergman, Head of Strategic Initiatives, AI Sweden, Sweden

Johanna Ulfvarson, Professor, Senior adviser, International Coordinator, eHälsomyndigheten, Sweden

Jon Amund Kyte, Group leader, Senior consultant, Oslo University Hospital, Norway

Julie Smith, Senior Lecturer in Medical Laboratory Science, University College Copenhagen, Denmark

Julien Masliah Planchon, Molecular Biologist, Institut Curie, France

Katharina Wassilew, Consultant Histopathologist, Royal Brompton and Harefield Hospitals, Part of Guy’s and St. Thomas’ NHS Foundation Trust, UK

Katriina Peltola, Head Physician, Associate Professor, Clinical Trial Unit, Helsinki Comprehensive Cancer Center, Finland

Khalid Shah, Vice Chair of Research, Brigham and Women’s Hospital, Director, Center for Stem Cell Therapeutics and Imaging, Harvard Medical School, USA

Kjetil Taskén, Professor, Head Institute for Cancer Research, Division of Cancer Medicine, University of Oslo, Norway

Klaus Pantel, Professor of Medicine, Director & Chairman, University Medical Center Hamburg, Germany

Kristian Hveem, Professor in Clinical Epidemiology and Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Kristoffer Rohrberg, Head of Phase 1 Unit, Dept. of Oncology, Copenhagen University Hospital – Rigshospitalet, Denmark

Lisa Vervueren, Internal pharmaceutical expert, RIZIV-INAMI, Belgium

Luca Gattinoni, Professor, Director of the Department for Functional Immune Cell Modulation, Regensburg Center for Interventional Immunology, Germany

Luigi de Petri, Senior Consultant, Thoracic Oncology Center, Karolinska University Hospital, Sweden

Malin Johansson, Global Head of Digital Health Strategic Partnerships, Novo Nordisk, Denmark

Margareta Haag, Chairperson, Network Against Cancer, Sweden

Markus Perola, Research Professor, Finnish Institute for Health and Welfare (THL), Finland

Mathias Uhlen, Professor of Microbiology, KTH School of Engineering Sciences in Chemistry, Sweden

Matt Brown, Professor, Chief Scientific Officer, Genomics England, UK

Mattias Rantalainen, Co- founder of Stratipath, and Associate Professor, Karolinska Institutet, Sweden

Maud Kamal, Scientific Manager, Department of Drug Development and Innovation, Institut Curie, France

Maxine Mackintosh, Programme Lead for Diverse Data, Genomics England, UK

Merel Hennink, Patient advocate, Merels World Foundation, Netherlands

Michael Uhlin, Head of the Division of Clinical Immunology, Karolinska University Hospital, Adjunct Professor of Clinical Immunology, Karolinska Institutet, Sweden

Michael Wierer, Director of the Proteomics Research Infrastructure, University of Copenhagen, Denmark

Minetta Liu, Chief Medical Officer of Oncology, Natera, USA

Nasim Farrokhnia, Healthcare Executive, Microsoft Western Europe, Sweden

Nick Guldemond, Professor Healthcare and Public Health, Leiden University Medical Center, Netherlands

Nils-Olav Refsdal, Assistant Director General, Norwegian Ministry of Health and Care Services, Norway

Nina Linder, Associate Professor, Uppsala University and University of Helsinki, FIMM, Finland

Olivia Rekman, Innovation Adviser, AI & Data program, Nordic Innovation (Nordic Council of Ministers), Norway

Päivi Östling, Scientific Lead for Precision Medicine, SciLifeLab and Karolinska Institutet, Sweden

Paul Franks, Head, Dept Translational Medicine and Scientific Director in Medical Science, Novo Nordisk Foundation, Denmark

Paul Frohna, Chief Medical Officer, Imcheck, France

Pekka Ruusuvuori, Assistant Professor, PI in Bioimage informatics Institute of Biomedicine, University of Turku, Finland

Peter Alex, CEO, Beep Insights, Sweden

Peter Asplund, Project Director, MEGALiT, Director Department of Anestethic and Intensive Care, Region Örebro Län, Örebro, Sweden

Peter Kelly, Emergency Physician, Head of Sahlgrenska University Hospital Innovation and Technology Physician Group, Sahlgrenska University Hospital, Sweden

Richard Rosenquist Brandell, Chair of GMS management team, Professor and Senior Physician in Clinical Genetics, Karolinska Institutet, Sweden

Robert Berling, Co-founder and Medical Lead, Beep Insights, Sweden

Ronny Öhman, Senior Physician in Pulmonary Medicine, Skane University Hospital, Sweden

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Pharmacist Medicine & Society, CZ insurance, Netherlands

Sari Pesonen, Co-founder and CSO, Valo Therapeutics, Finland

Sigrid Skånland, Project Group Leader, Lab leader and Researcher, Oslo University Hospital, Sweden

Sigurdis Haraldsdottir, Physician-in-Chief, Medical Oncology, Landspitali University Hospital Associate Professor, University of Iceland, Iceland

Simon Nilsson, Chief Development Officer, Region Gävleborg, Sweden

Siv Andersson, Professor, Uppsala University, Director of Basic Research, Knut and Alice Wallenberg Foundation, Sweden

Stina Wickström, Assistant Professor, Karolinska Institutet, Sweden

Theodoros Foukakis, Associate Professor of Oncology, Senior Consultant, Karolinska Institutet and University Hospital, Sweden

Tobias Sjöblom, Professor, Department of Immunology, Uppsala University, Sweden

Toni Andreu, Scientific Director, EATRIS | European Infrastructure for Translational Medicine, Netherlands

Tzahi Neuman, Senior pathologist, Deputy head, department of diagnostic pathology, The Hebrew University of Jerusalem, Israel

Ulrik Lassen, Clinical Professor, Copenhagen University Hospital, Denmark

Volker Liebenberg, Chief Medical Officer, Elypta, Sweden

Zoher Kapacee, Head of Data and AI, Health Research Authority, UK

Why You Should Join Us in Stockholm

As Precision Medicine initiatives around the world gather pace, the Nordic countries are in an enviable position when it comes to joining all the dots. The link between digital health, omics technologies, artificial intelligence and data means that yet more collaboration is required to ensure the success of precision medicine. As demonstrated by organisations such as SciLifeLab, the collaborative efforts of healthcare, research, industry and patient organisations is really starting to bear fruit.

Sponsorship Opportunities

Nordic Precision Medicine Forum offers a unique environment to make new connections, share ideas and formulate partnerships for future collaboration. We work closely with our sponsors to ensure that your objectives are met by building bespoke marketing solutions. So be it a plenary speaking slot, hosting a roundtable or exhibiting at our forum, we ensure you are in front of the right audience.

Scroll to Top